Back to search
FDAFDA · Food and drugs·Recall number D-179-2013

Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30

Published March 6, 2013 · Recall initiated: August 1, 2012

Summary

FDA records drug Class II recall D-179-2013, published March 6, 2013 and initiated August 1, 2012. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 86, 093 bottles; Lot: Lot #: C201922, Exp 1/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide
Lot
Lot #: C201922, Exp 1/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30 recalled?

Yes. FDA published recall D-179-2013 on March 6, 2013. Reported hazard: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

What should I do if I have this product?

Voluntary: Firm initiated · Letter